This test is most useful if any of these apply to you.
If your stools have been loose, greasy, and foul-smelling for more than a week or two after a camping trip, foreign travel, or drinking untreated water, one specific parasite is a prime suspect. This test looks for it directly, by catching proteins the parasite sheds into your stool while it is living in your gut.
The reason this matters is that the parasite hides well. It lives high in the small intestine and releases its dormant forms in irregular bursts, so the old approach of searching for it under a microscope can miss a third of infections on a single sample, and in some settings close to half. Catching shed antigen instead is usually more reliable.
The parasite is Giardia duodenalis, also called Giardia lamblia, a single-celled organism you swallow as a hardy cyst in contaminated water or food. Inside your gut it wakes up and attaches to the first stretches of the small intestine. Those stretches are called the duodenum and jejunum. The parasite multiplies on the surface without invading tissue.
As it colonizes, it sheds proteins into the gut. The test uses an enzyme immunoassay, a lab method that uses antibodies to grab Giardia-specific proteins in stool. Some classic kits target a marker called GSA-65; other kits target related Giardia antigens. A positive result means those proteins are in your stool now or were recently shed, which points to active or very recent infection.
This is a direct marker of the parasite itself, not a measure of your immune response. That distinction matters. A blood antibody test can stay positive for months after the parasite is gone.
Active infection classically causes acute watery diarrhea, cramping, bloating, nausea, and pale greasy stools that float, a sign the gut is failing to absorb fat. Worldwide, clinically diagnosable giardiasis is estimated at about 280 million cases a year. Many infections are mild or pass on their own, but a stubborn one can drag on for weeks and drain nutrients.
The parasite is unusual because it often triggers little gut inflammation. It can flatten parts of the intestinal lining and increase gut leakiness while looking bland on standard inflammatory stool tests. That is part of why it gets missed: it does not always announce itself the way a bacterial infection does.
The surprising part of this infection is what can happen after it is gone. Following a large waterborne outbreak, people who had been infected went on to develop irritable bowel syndrome and lasting fatigue at much higher rates than uninfected neighbors. Fatigue tended to fade over time, while IBS remained elevated for years. Separate insurance-record and meta-analysis data point the same way: gut infections raise the odds of later IBS several-fold.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| About 1,900 adults after a waterborne outbreak in Norway | IBS three years later, infected versus not | Much higher rate of IBS and chronic fatigue in the infected group |
| About 23,600 people in US insurance records | New IBS diagnosis after a giardiasis diagnosis | More likely to be diagnosed with IBS, even after accounting for other factors |
| Pooled patients across many studies of gut infection | IBS after any infectious gut illness | Roughly four times the risk compared with people who had no such infection |
Sources: Wensaas et al. 2011 (Gut); Nakao et al. 2017 (J Infect Dis); Klem et al. 2017 (Gastroenterology).
What this means for you: if you have unexplained IBS-type symptoms, especially after a bout of travel or camping diarrhea that never fully settled, a lingering untreated infection is worth checking for. A negative antigen test cannot prove a past infection never happened.
In young children, this infection carries a quieter risk. In a large birth-cohort study, children who carried the parasite persistently before six months of age were lighter at age two, with a weight-for-age deficit of about a third of a standard unit. Giardia detection was also linked with a leakier intestinal barrier, whether or not the child had diarrhea. Other cohorts link early infection to stunting. If your child has faltering growth and known exposure, this test belongs in the workup.
For many commercial antigen assays, published sensitivity is in the mid-90s to 100% range, with specificity usually around 99 to 100%. A single microscope exam often catches only about two-thirds to three-quarters of cases, because it depends on spotting whole cysts that are shed in bursts. In one classic GSA-65 study, the antigen test found nearly 30% more cases than microscopy. In the MAL-ED birth cohort, microscopy found fewer than half the infections detected by stool EIA.
One caveat: kits are not interchangeable. In head-to-head testing on the same samples, sensitivity was about 73% for a weaker kit and about 94% for a stronger one. Across other commercial-kit evaluations, some assays reached 100%. The lab you use, and the kit it runs, affects how many infections get caught.
A newer option is PCR, a method that detects the parasite's DNA. In careful evaluations, high-performing Giardia PCR assays reach about 98% sensitivity, can find a few cases antigen testing misses, and often come bundled in stool panels that screen many gut pathogens at once. The antigen test remains simpler, cheaper, and fast, so it is a strong first-line choice. PCR adds yield and breadth when the picture is unclear or many pathogens are in play.
Because the parasite sheds in bursts, one specimen is not the same as being done. In one paired-sample study, a single antigen specimen caught about 80% of infected people, while a single microscope exam caught about two-thirds. Testing two samples collected on separate days pushed either method above 90%. In the same study, even a highly sensitive assay missed a small share of confirmed infections on both samples. If you have real symptoms and a single test is negative, a second sample on another day is the right next step, not reassurance.
Testing after treatment takes more care. Successfully treated stools convert to antigen-negative once the parasite is cleared, which makes the test useful for confirming a cure when symptoms persist. But timing matters. Soon after treatment, when few organisms remain, a rapid antigen test can miss lingering infection, with sensitivity falling to about 61% in persistent cases. CDC guidance also recommends waiting at least two weeks after the last dose before retesting if symptoms continue. Wait, then retest with multiple samples, rather than assuming a same-week negative means you are clear.
A positive with matching symptoms points to treatment, and it is reasonable to pair the test with a Cryptosporidium test and a full ova-and-parasite exam if your exposure could involve more than one bug, since the antigen test sees only this one parasite. A negative in someone who is still sick calls for a second specimen on another day, or a molecular stool panel that screens more broadly.
If symptoms persist after treatment, do not lean on a single rapid antigen result. Confirm with multiple stool samples by antigen testing, microscopy, or PCR, and weigh two very different possibilities: a resistant or reinfecting parasite, or a post-infectious syndrome where the parasite is already gone but the gut has not recovered. Those lead to opposite next steps, so getting the distinction right is the point of retesting.
One result confuses people: a positive antigen test when no cysts are seen under the microscope. Usually this is not a false alarm. The antigen test is more sensitive and detects protein the microscope cannot see, so these results often hold up as true infections. Think of a positive as evidence the parasite is present, not as a good or bad number. Whether it is making you sick depends on you. In some high-exposure childhood settings the parasite is often carried without symptoms and has even looked protective against other diarrheal bugs, but that does not mean ignoring a positive when you have symptoms it explains.
Evidence-backed interventions that affect your Giardia Antigen level
Giardia Antigen is best interpreted alongside these tests.
Giardia Antigen is included in these pre-built panels.